Med/Surg: Arrhythmias and Pacemakers Flashcards
1
Q
What are the normal durations for each of the ECG waveforms and intervals?
A
- P wave: 0.06 - 0.12
- PR Interval: 0.12 - 0.20
- QRS Interval: < 0.12
- ST Segment: 0.12
- T wave: 0.16
- QT Interval: 0.34 - 0.43
2
Q
What are the intrinsic rates of the conduction system?
A
- SA node: 60-100 times/min
- AV node: 40-60 times/min
- Bundle of His, Purkinje fibers: 20-40 times/min
3
Q
What are the common cardiac conditions that causes dysrhythmias?
A
- Accessory pathways
- Cardiomyopathy
- Conduction defects
- Heart failure
- Myocardial ischemia, infarction
- Valve disease
4
Q
What are the initial interventions for dysrhythmias?
A
- Ensure ABCs
- Administer 02 via nasal cannula or non-rebreather mask
- Obtain baseline vital signs, including O2 saturation
- Obtain 12-lead ECG
- Initiate continuous ECG monitoring
- Identify underlying rate and rhythm
- Identify dysrhythmia
- Establish IV access
5
Q
What are the ongoing monitoring interventions for dysrhythmia?
A
- Monitor vita signs, level of consciousness, O2 saturation, and cardiac rhythm.
- Anticipate need for administration of antidysrhythmia drugs and analgesics.
- Anticipate need for intubation if respiratory distress is evident.
- Prepare to initiate cardiac support (eq. CPR, defibrillation, transcutaneous pacing)
6
Q
What are the common states associated with sinus bradycardia?
A
- Hypothyroidism
- Increased intracranial pressure
- Hypoglycemia
- Inferior wall myocardial infarction (MI)
7
Q
What is the common ECG characteristics and treatment for sinus bradycardia?
A
Characteristics:
- HR less than 60. Normal ECG
Treatment:
- Administration of atropine (anticholinergic drug).
- Pacemaker may be required
- If caused by drugs, held or discontinued.
8
Q
What is the common ECG characteristics and treatment for sinus tachycardia?
A
ECG Characteristics:
- HR 101 - 200 beats/min
- Normal characteristics
Treatment:
- If from pain, effective pain management
- Treating hypovolemia
- if clinically stable, vagal maneuvers
- In addition, beta blockers
9
Q
A